CPT® Code 87324 is used to report an immunoassay for the detection of Clostridium difficile toxin. The test can help evaluate patients with symptoms suggestive of C. difficile infection (CDI), particularly diarrhea following antibiotic exposure or healthcare-associated illness.
The test detects C. difficile toxin using an immunoassay methodology.
Key Facts About CPT® Code 87324
- Service type: Microbiology laboratory testing
- Test: Clostridium difficile toxin immunoassay
- Method: Enzyme immunoassay (EIA)
- Specimen: Typically stool
- Purpose: Detect C. difficile toxin
- Common specialties: Infectious disease, gastroenterology, primary care, internal medicine
- Provider type: Clinical laboratory
Common clinical uses:
- Evaluation of suspected C. difficile infection
- Acute or persistent diarrhea with an appropriate clinical history
- Diarrhea following antibiotic exposure
- Evaluation of healthcare-associated diarrhea
When to Use CPT® 87324
CPT 87324 may be reported when an appropriate immunoassay is performed to detect C. difficile toxin in a clinical specimen.
Examples:
- A patient develops significant diarrhea after a course of antibiotics
- A clinician evaluates suspected C. difficile infection in a hospitalized patient
- Stool testing is performed when the patient's symptoms and clinical history support evaluation for CDI
Testing should be ordered and interpreted according to current clinical guidelines and laboratory protocols.
Documentation Requirements
Documentation supporting CPT 87324 should include:
- Patient identifiers and date of service
- Clinical indication for testing
- Relevant symptoms, particularly diarrhea
- Relevant medical or medication history when applicable
- Specimen collected
- Testing method
- Test result
- Provider or laboratory authentication
The medical record should support the clinical reason for testing and the laboratory service performed.
Reimbursement and Coding Considerations
- CPT 87324 represents immunoassay detection of Clostridium difficile toxin
- Additional testing for C. difficile, such as nucleic acid amplification testing, may use a different code when performed
- Testing should follow applicable laboratory and clinical protocols
- Medical necessity and coverage requirements vary by payer
- Practices should verify current payer-specific policies before submitting claims
Accurate documentation of the patient's symptoms, clinical indication, specimen, and test performed helps support appropriate coding and reimbursement.
How OptiMantra Supports Laboratory Documentation
OptiMantra helps practices organize laboratory results, symptoms, diagnoses, and treatment plans within the patient's medical record.
With OptiMantra, providers can:
- Document indications for infectious disease testing
- Record C. difficile test results
- Review laboratory findings within the patient chart
- Link test findings to diagnoses and treatment plans
- Use customizable chart templates for consistent documentation
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)




